← Leaderboards
Michael Conte
University Of California, San Francisco
$2,124,160
Attributed
$2,124,160
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $628.8K · FY2014–19$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,124,160 · 2
By mechanism
N01$2,124,160 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Christopher Dean Owens$1,282,863
- Michael Douglas Hope$1,562,586
- Akiko Hata$14,386,243
- Douglas N Miniati$741,780
- Adam Oskowitz$1,096,626
Others in their field
Top investigators on “Devices”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$199,696,645
- David Heimbrook · Leidos Biomedical Research, Inc.$141,696,528
- Daniel Ernest Ford · Johns Hopkins University$129,841,670
- Richard A Gibbs · Baylor College Of Medicine$118,056,644
Research focus
DevicesBypassVascular DiseasesProduct DevelopmentOperative Surgical ProceduresProgramsPreventPulmonary HypertensionAnimalsCicatrixBaseComplicationContractsCoronary ArteriosclerosisAnalogAreaHyperplasiaInflammationDissectionAngioplastyGraft FailureHealedHealingDiagnostic
Grant awards (6)
IGF::OT::IGF PREVENTION OF ANASTOMOTIC INTIMAL HYPERPLASIA BY A PRO-RESOLVING PERIVASCULAR DEVICE$63,194
N01 · FY2019 · HL · contact PI
IGF::OT::IGF PREVENTION OF ANASTOMOTIC INTIMAL HYPERPLASIA BY A PRO-RESOLVING PERIVASCULAR DEVICE$628,793
N01 · FY2018 · HL · contact PI
IGF::OT::IGF PREVENTION OF ANASTOMOTIC INTIMAL HYPERPLASIA BY A PRO-RESOLVING PERIVASCULAR DEVICE$484,404
N01 · FY2017 · HL · contact PI
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES BASE PERIOD: NOVEMBER 15, 2013 - NOVEMBER 14, 2014$346,659
N01 · FY2016 · HL · contact PI
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES BASE PERIOD: NOVEMBER 15, 2013 - NOVEMBER 14, 2014$295,153
N01 · FY2015 · HL · contact PI
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES BASE PERIOD: NOVEMBER 15, 2013 - NOVEMBER 14, 2014$305,957
N01 · FY2014 · HL · contact PI